 |
Top Story
What's In the Pipeline? A Look at Pharm Exec's 2016 Report
Editor-in-Chief William Looney looks at this year’s Pharm Exec product pipeline report and identifies four key themes that are driving the fast-changing environment for drug development
...Read more |
 |
Event
Strength of the Few
Rare disease advocates seem to have something to say to the industry, “Our work is important and amazing. We have made great progress, but there is so much more to do!” This, or something catchier, could easily have been the slogan for this year’s summit held by the National Organization for Rare Disorders (NORD) in Arlington, Virginia, in October. Casey McDonald reports
...Read more |
 |
Supply Chain
The Push for a Pull Supply Chain
Experts are warning that if pharma doesn't take a tighter grip on its supply chain and yank it into the 21st century, the industry could soon face distribution and logistics crises on an unprecedented scale.
...Read more |
Free White Paper “Hiding in Plain Sight: Copay as the Key to Patient Engagement.” How is our changing healthcare landscape influencing patient affordability programs? Go beyond traditional approaches and see how Pharma is defining program success in the new value-based healthcare landscape.
 Learn more |
Comment
Walgreens: Purveyor or Provider?
An intriguing question emerged from the merger announcement from Walgreens Boots Alliance and Rite Aid, writes Stephen Littlejohn. Led by CEO Stefano Pessina and his largely European executive team, will Walgreens be purveyor focused on retail sales or provider engaged with a transforming U.S. healthcare system?
...Read more |
 |
Comment
What Lessons Can the World Learn from Ebola?
What the Ebola virus showed was that taking on high-risk innovation can reap rewards. But too many businesses are scared to take a bold step into the unknown and are preventing potentially brilliant ideas from making it to market, writes Neil Saward
...Read more |
Orchestrated Customer Engagement
What is the next generation of
sales, marketing and technology beyond MCM and OCM? And can this next generation's
approach to customer engagement improve the relationship between Life Sciences companies
and their customers, and increase efficiencies across all channels of communication while
bolstering ROI?
 Learn more |
 |
 //Manuel Hidalgo, MD, PhD, a member of the Scientific Advisory Board of PharmaCyte Biotech (Silver Springs, MD) has been named Clinical Director of the Leon V. & Marilyn L. Rosenberg Clinical Cancer Center, part of the Cancer Center at the Beth Israel Deaconess Medical Center (BIDMC) in Boston, MA.//AmpliPhi Biosciences Corporation (San Diego, CA; Richmond, VA; Ljubljana, Slovenia; and Sydney, Australia) announced that Vijay B. Samant and Paul C. Grint, M.D. have been appointed to its Board of Directors as Non-Executive Directors.//BeyondSpring Pharmaceuticals (New York, NY) appointed Ramon Mohanlal, M.D., Ph.D., as Chief Medical Officer and Robert Dickey IV, MBA as Chief Financial Officer.// |
|
Pharmaceutical Executive E-Book – Coming November 2015: Securing the Global Supply Chain: Strategies for Operational Excellence
Key Topics include:
- Compliance Groundswell: What are the New Rules and Regulator Expectations?
- Global Dynamics of Risk: Can Technology Keep Pace?
- Benchmarking Best Practices: Upgrading Company Performance Culture
- What's Ahead: How Logistics and Distribution Science will Shape Tomorrow's Supply Chain
 Contact your sales rep for more information and to secure your sponsorship. |
|
|
|
